Delivery Platform

We offer the development of encapsulated drugs for all kinds of pharmaceutically active ingredients based on various lipid-
based formulations* such as:

*The developed formulations are tested in accordance with the QbD (Quality by Design) and ICH guidelines.

for gene therapies (both DNA & RNA)

Discovery Phase

1A. Building a library of potential formulations
2A. Performing in vitro screening tests, including determination of the potential toxicity of excipients
3A. Selection of auxiliary substances for further research

Early Preclinical

1B. Determination of the key composition and critical process parameters
2B. Physicochemical characteristics of the formulation along with research and appropriate biological models
3B. Selection of the best formulations for further testing, together with the determination of key test parameters

Late Preclinical

1C. Refining the manufacturing process
2C. Determination of toxicity, PK, BD, in appropriate biological models
3C. Selection of candidates for the GMP scale up process

Clinical Development

1D. Production of batches for clinical trials